Desferrithiocin analogue actinide decorporation agents
AssigneeUniversity of Florida Research Foundation, Inc.
InventorRaymond J. Bergeron, JR.
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition comprising a non-toxic effective amount of an actinide decorporation agent and a pharmaceutically acceptable carrier therefore, the actinide decorporation agent comprising a hexacoordinate desferrithiocin analogue capable of chelating an actinide in vivo and a method for removing an actinide from the tissue of a human or nonhuman mammal.
Claims3
A pharmaceutical composition comprising a non-toxic effective amount of an actinide decorporation agent and a pharmaceutically acceptable carrier therefore, said actinide decorporation agent comprising a hexacoordinate desferrithiocin analog capable of chelating an actinide in vivo.
Dependencies are inferred from the claim text.